biospecimen_aliquot__bcr_aliquot_barcode	tcga-ew-a1p4-01a-21d-a142-09
biospecimen_aliquot__bcr_aliquot_uuid	204e4ef3-e6b8-469f-9024-56c6f6f07afd
biospecimen_aliquot__bcr_patient_uuid	521e2140-ae5b-456f-8699-97398d009687
biospecimen_aliquot__bcr_sample_barcode	tcga-ew-a1p4-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0100474746
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.09
biospecimen_aliquot__date_of_shipment	2011-04-06
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	4
biospecimen_aliquot__plate_id	a142
biospecimen_aliquot__plate_row	d
biospecimen_aliquot__quantity	3.60
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__a260_a280_ratio	1.84
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-ew-a1p4-01a-21d
biospecimen_analyte__bcr_analyte_uuid	71d2ab6c-819d-4458-9fea-c9aa45852a37
biospecimen_analyte__bcr_patient_uuid	521e2140-ae5b-456f-8699-97398d009687
biospecimen_analyte__bcr_sample_barcode	tcga-ew-a1p4-01a
biospecimen_analyte__concentration	0.18
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-ew-a1p4
biospecimen_diagnostic_slides__bcr_patient_uuid	521e2140-ae5b-456f-8699-97398d009687
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-ew-a1p4-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	3e9ae553-83d4-4b09-ab7f-d096bce3bc4d
biospecimen_normal_control__bcr_patient_barcode	tcga-ew-a1p4
biospecimen_normal_control__bcr_patient_uuid	521e2140-ae5b-456f-8699-97398d009687
biospecimen_portion__bcr_patient_uuid	521e2140-ae5b-456f-8699-97398d009687
biospecimen_portion__bcr_portion_barcode	tcga-ew-a1p4-01a-21
biospecimen_portion__bcr_portion_uuid	b58e164a-2db3-4fd5-a3c9-8bd175b3d1d8
biospecimen_portion__bcr_sample_barcode	tcga-ew-a1p4-01a
biospecimen_portion__date_of_creation	2011-03-24
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	21
biospecimen_portion__portion_sequence	2
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-ew-a1p4-01a-21d
biospecimen_protocol__bcr_patient_uuid	521e2140-ae5b-456f-8699-97398d009687
biospecimen_protocol__bcr_sample_barcode	tcga-ew-a1p4-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	521e2140-ae5b-456f-8699-97398d009687
biospecimen_sample__bcr_sample_barcode	tcga-ew-a1p4-01a
biospecimen_sample__bcr_sample_uuid	7a3b5790-35c8-473a-b952-bb603aca5aa1
biospecimen_sample__days_to_collection	525
biospecimen_sample__initial_weight	290
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-ew-a1p4.70c8d54a-9698-4275-bd96-a6ef2e26474b.pdf
biospecimen_sample__pathology_report_uuid	70c8d54a-9698-4275-bd96-a6ef2e26474b
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	521e2140-ae5b-456f-8699-97398d009687
biospecimen_shipment_portion__bcr_sample_barcode	tcga-ew-a1p4-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	b7cf8b60-fd76-4c2c-aa8e-cc0d0c89009a
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a17j
biospecimen_shipment_portion__portion_number	11
biospecimen_shipment_portion__portion_sequence	1
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-ew-a1p4-01a-11-a17j-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	2
biospecimen_shipment_portion__shipment_portion_month_of_shipment	8
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	521e2140-ae5b-456f-8699-97398d009687
biospecimen_slide__bcr_sample_barcode	tcga-ew-a1p4-01a
biospecimen_slide__bcr_slide_barcode	tcga-ew-a1p4-01a-02-tsb
biospecimen_slide__bcr_slide_uuid	4e509c5d-75a2-4996-a202-32910c7b745a
biospecimen_slide__image_file_name	tcga-ew-a1p4-01a-02-tsb.4e509c5d-75a2-4996-a202-32910c7b745a.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	3
biospecimen_slide__percent_monocyte_infiltration	1
biospecimen_slide__percent_necrosis	5
biospecimen_slide__percent_neutrophil_infiltration	1
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	15
biospecimen_slide__percent_tumor_cells	80
biospecimen_slide__percent_tumor_nuclei	80
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-ew-a1p4
biospecimen_tumor_sample__bcr_patient_uuid	521e2140-ae5b-456f-8699-97398d009687
clinical_drug__bcr_drug_barcode	tcga-ew-a1p4-d29689
clinical_drug__bcr_drug_uuid	e8073733-f67a-40f9-88da-22013c8ed597
clinical_drug__bcr_patient_barcode	tcga-ew-a1p4
clinical_drug__bcr_patient_uuid	521e2140-ae5b-456f-8699-97398d009687
clinical_drug__form_completion_date	2012-3-26
clinical_drug__pharma_adjuvant_cycles_count	4
clinical_drug__pharmaceutical_therapy_drug_name	cyclophosphamide
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_dose_units	mg/m2
clinical_drug__pharmaceutical_tx_ended_days_to	144
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	73
clinical_drug__prescribed_dose	600
clinical_drug__regimen_number	tc
clinical_drug__route_of_administration	iv
clinical_drug__therapy_regimen	adjuvant
clinical_follow_up__bcr_followup_barcode	tcga-ew-a1p4-f29684
clinical_follow_up__bcr_followup_uuid	45eab7c6-bfbf-48ec-b18c-19642b61c70e
clinical_follow_up__bcr_patient_barcode	tcga-ew-a1p4
clinical_follow_up__bcr_patient_uuid	521e2140-ae5b-456f-8699-97398d009687
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2012-3-26
clinical_follow_up__last_contact_days_to	907
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	43
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n0 (i-)
clinical_patient__ajcc_pathologic_tumor_stage	stage iia
clinical_patient__ajcc_staging_edition	6th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left upper outer quadrant
clinical_patient__axillary_staging_method	sentinel node biopsy alone
clinical_patient__bcr_patient_barcode	tcga-ew-a1p4
clinical_patient__bcr_patient_uuid	521e2140-ae5b-456f-8699-97398d009687
clinical_patient__birth_days_to	-15989
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_positivity_scale_used	3 point scale
clinical_patient__er_status_by_ihc	negative
clinical_patient__er_status_ihc_Percent_Positive	<10%
clinical_patient__ethnicity	hispanic or latino
clinical_patient__form_completion_date	2011-5-11
clinical_patient__gender	female
clinical_patient__her2_ihc_percent_positive	<10%
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	medullary carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8510/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2009
clinical_patient__last_contact_days_to	501
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	3
clinical_patient__lymph_nodes_examined_he_count	0
clinical_patient__lymph_nodes_examined_ihc_count	0
clinical_patient__margin_status	negative
clinical_patient__menopause_status	pre (<6 months since lmp and no prior bilateral ovariectomy and not on estrogen replacement)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	yes
clinical_patient__patient_id	a1p4
clinical_patient__pr_positivity_scale_used	3 point scale
clinical_patient__pr_status_by_ihc	negative
clinical_patient__pr_status_ihc_percent_positive	<10%
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	simple mastectomy
clinical_patient__tissue_source_site	ew
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-ew-a1p4
clinical_radiation__bcr_patient_uuid	521e2140-ae5b-456f-8699-97398d009687
clinical_radiation__bcr_radiation_barcode	tcga-ew-a1p4-r29685
clinical_radiation__bcr_radiation_uuid	1b09106f-d19a-436a-ae7e-6de51ba1a9b4
clinical_radiation__course_number	1
clinical_radiation__form_completion_date	2012-3-26
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	263
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	208
clinical_radiation__radiation_therapy_type	external beam
clinical_radiation__radiation_total_dose	15,900
clinical_radiation__therapy_regimen	adjuvant
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-EW-A1P4-01A-21D-A142-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-EW-A1P4-01A-21D-A142-09.bed.meta
manually_curated__id	tcga-ew-a1p4-01a-21d-a142-09
manually_curated__md5sum	0c2ef84f2a77eb74db611c951a303310
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	204e4ef3-e6b8-469f-9024-56c6f6f07afd
manually_curated__tumor_tag	brca
